Nothing Special   »   [go: up one dir, main page]

DK491087A - Tumor-egress-faktor (egressin) og fremgangsmaade til fremstilling heraf - Google Patents

Tumor-egress-faktor (egressin) og fremgangsmaade til fremstilling heraf

Info

Publication number
DK491087A
DK491087A DK491087A DK491087A DK491087A DK 491087 A DK491087 A DK 491087A DK 491087 A DK491087 A DK 491087A DK 491087 A DK491087 A DK 491087A DK 491087 A DK491087 A DK 491087A
Authority
DK
Denmark
Prior art keywords
egressin
tumor
procedures
producing
egress
Prior art date
Application number
DK491087A
Other languages
English (en)
Other versions
DK491087D0 (da
Inventor
Joseph E De Larco
Marjorie L Wier
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of DK491087D0 publication Critical patent/DK491087D0/da
Publication of DK491087A publication Critical patent/DK491087A/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK491087A 1986-09-19 1987-09-18 Tumor-egress-faktor (egressin) og fremgangsmaade til fremstilling heraf DK491087A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90935686A 1986-09-19 1986-09-19
US07/096,576 US5039794A (en) 1986-09-19 1987-09-15 Tumor egress factor and processes for producing the same

Publications (2)

Publication Number Publication Date
DK491087D0 DK491087D0 (da) 1987-09-18
DK491087A true DK491087A (da) 1988-03-20

Family

ID=26791847

Family Applications (1)

Application Number Title Priority Date Filing Date
DK491087A DK491087A (da) 1986-09-19 1987-09-18 Tumor-egress-faktor (egressin) og fremgangsmaade til fremstilling heraf

Country Status (4)

Country Link
US (1) US5039794A (da)
EP (1) EP0260708A3 (da)
KR (1) KR910002703B1 (da)
DK (1) DK491087A (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346988A (en) * 1990-06-20 1994-09-13 Tampa Bay Research Institute Process for obtaining cellular protein having anti-HIV activity
US5827819A (en) * 1990-11-01 1998-10-27 Oregon Health Sciences University Covalent polar lipid conjugates with neurologically active compounds for targeting
US5543390A (en) 1990-11-01 1996-08-06 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Covalent microparticle-drug conjugates for biological targeting
US5643881A (en) * 1994-08-04 1997-07-01 Tampa Bay Research Institute Protein having anti-HIV activity and method for obtaining it
WO1998039967A1 (en) * 1997-03-12 1998-09-17 The General Hospital Corporation A method for treating or preventing alzheimer's disease
US20040058873A1 (en) * 1998-03-12 2004-03-25 Esmond Robert W. Method for treating or preventing Alzheimer's disease
ATE476978T1 (de) * 1998-12-17 2010-08-15 Mindset Biopharmaceuticals Usa Verbesserung der geistigen fähigkeiten durch die steigerung der insulin-empfindlichkeit des gehirns
US7045543B2 (en) 2001-11-05 2006-05-16 Enzrel Inc. Covalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20060183800A1 (en) * 2004-11-12 2006-08-17 Xianqi Kong Methods and fluorinated compositions for treating amyloid-related diseases
JP2008520647A (ja) * 2004-11-16 2008-06-19 ニューロケム （インターナショナル） リミテッド Ｃｎｓおよびアミロイド関連疾患治療のための化合物
AU2005326962A1 (en) * 2004-12-22 2006-08-17 Bellus Health (International) Limited Methods and compositions for treating amyloid-related diseases
US20070232556A1 (en) * 2006-03-31 2007-10-04 Montine Thomas J Methods and compositions for the treatment of neurological diseases and disorders
US20100316626A1 (en) * 2006-08-11 2010-12-16 The Government Of The United States Of America As Represented By The Secretary Methods for treatment and diagnosis of psychiatric disorders
BRPI0717794B8 (pt) 2006-10-12 2021-05-25 Bellus Health International Ltd composto e composição farmacêutica de ácido 3-amino-1-propanosulfônico
EP2342356A4 (en) 2008-09-29 2012-11-21 Univ Ben Gurion AMYLOID BETA PEPTIDASES AND METHOD OF USE THEREOF
CA3066077A1 (en) 2017-06-07 2018-12-13 Adrx, Inc. Tau aggregation inhibitors
WO2019036725A2 (en) 2017-08-18 2019-02-21 Adrx, Inc. PEPTIDE INHIBITORS OF TAU AGGREGATION

Also Published As

Publication number Publication date
KR880003901A (ko) 1988-05-31
EP0260708A2 (en) 1988-03-23
KR910002703B1 (ko) 1991-05-03
DK491087D0 (da) 1987-09-18
US5039794A (en) 1991-08-13
EP0260708A3 (en) 1988-11-17

Similar Documents

Publication Publication Date Title
DK166087D0 (da) Proteiner og fremgangsmaade til fremstilling deraf
DK522487A (da) Imidazopyridinforbindelse og fremgangsmaade til fremstilling deraf
DK3687A (da) Polypeptider og fremgangsmaade til fremstilling deraf
DK664887D0 (da) 3-substituerede 3-aroyloxy-propanaminer og fremgangsmaade til fremstilling deraf
DK491087D0 (da) Tumor-egress-faktor (egressin) og fremgangsmaade til fremstilling heraf
DK521887A (da) Substituerede pyrazoliner og fremgangsmaade til fremstilling deraf
DK290287D0 (da) Antibiotika og fremgangsmaade til fremstilling deraf
DK315085D0 (da) Isoinsolinyl-alkyl-piperaziner og fremgangsmaade til fremstilling deraf
DK269987A (da) Enzym og fremgangsmaade til fremstilling deraf
DK315387D0 (da) Androst-4-en-3,17-dioner og fremgangsmaade til fremstilling deraf
DK203087D0 (da) Proteiner og fremgangsmaade til fremstilling deraf
DK477287A (da) Pyrido-benzoxadiazin-derivater og fremgangsmaade til fremstilling deraf
DK397788D0 (da) Polyarylalkan-oligomer-praeparater og fremgangsmaade til fremstilling deraf
DK163887A (da) Pesticider og fremgangsmaade til fremstilling deraf
DK362987D0 (da) Hexahydroarylquinolizin og fremgangsmaade til fremstilling deraf
DK270087A (da) Enzym og fremgangsmaade til fremstilling deraf
DK585988D0 (da) Isopolypeptider og fremgangsmaade til fremstilling deraf
DK265288D0 (da) Oximino-ether-forbindelser og fremgangsmaade til fremstilling deraf
DK286285D0 (da) Laktaseholdigt praeparat og fremgangsmaade til fremstilling deraf
DK467984A (da) 4-alkylmethylendioxy-2-1(h)-quinazolinoner og fremgangsmaade til fremstilling deraf
DK129689A (da) Ifosfamid-mesna-lyofilisat og fremgangsmaade til fremstilling deraf
DK20687A (da) Polypeptidforbindelser og fremgangsmaade til fremstilling deraf
DK319188A (da) Glycerolacetalaminoacylat og fremgangsmaade til fremstilling deraf
DK230286D0 (da) Phosphinguldforbindelser og fremgangsmaade til fremstilling deraf
NO165243C (no) Hoeysvovelholdige tioetere og fremgangsmaate til fremstilling derav.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment